From basics to clinic: Cancer Nanotechnology.,Cancer Nanotechnology

当前位置： X-MOL 学术 › Cancer Nanotechnol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

From basics to clinic: Cancer Nanotechnology.
Cancer Nanotechnology ( IF 4.5 ) Pub Date : 2017-11-10 , DOI: 10.1186/s12645-017-0033-1
Fred Currell ₁ , Steven Curley ₂ , Željka Krpetić ₃ , Mark Bellringer ₄

Affiliation

Cancer is a group of diseases driven by inherently nanostructural problems (e.g. DNA issues). As such, there are obvious benefits to treatments employing nanoscale structures and processes. Additionally, as nanotechnologies are developing at a rapid rate, it is likely that many new themes will develop within the area in the next few years. With this in mind, Cancer Nanotechnology aims to provide a forum so that the most promising emerging themes should be pre-eminent in the minds of researchers working in one—or, indeed, both—of the disciplines of cancer research or nanotechnology.

Cancer Nanotechnology is published by SpringerOpen, a suite of fully open access journals that is part of the wider Springer Nature group. It enjoys a growing readership with an ever-increasing number of papers receiving double-digit citations.

As we near the end of another year in the life of Cancer Nanotechnology, it is worth reflecting upon the journal’s raison d’être and future direction.

The label is very much on the tin! Cancer Nanotechnology concerns itself with all that is new at the intersection of cancer research and nanotechnology. Relationships to cancer are deliberately interpreted broadly, encompassing: prevention, treatment, diagnosis, and related regulatory frameworks. Nanotechnology is taken to mean anything involving objects with characteristic length scales typically below 500 nm, but also includes the induction of nanoscale processes, for example by the injection of energy or various substances.

These definitions are intentionally wide, and the journal continues this approach: submissions accepted range from fundamental discovery and creation of basic techniques—including all phases of development—to the clinical application of nano-processes and technologies in relation to cancer treatment, diagnosis, and prevention.

One distinctive feature of the journal is the hosting of special thematic article collections; each collection serves to illustrate a research area’s present status and/or to highlight cutting-edge developments.

Such a collection acts as a vehicle which the research community can use to make important connections explicit and more widely disseminated. Furthermore, a collection comprising mainly review articles has the scope to show historical trend, whilst one focusing on original research can capture disruptive change. Of course, a collection can contain a mix of original research and reviews, offering the opportunity to trace both historical trend and innovative discontinuity. If there is a substantive development at the intersection of cancer and nanotechnology, then it needs a special thematic article collection—the journal’s editorial team welcomes your suggestions in this regard.

What is more, a key feature of collections is that they are ever evolving. As an online-only publication, Cancer Nanotechnology is not constrained by the rules of traditional special issues, the print analogy to our special collections. This allows the special collections to be dynamic—they can be updated as new, relevant, research is reported even several years after the first papers comprising the collection came together.

It is possible that any of the papers found in Cancer Nanotechnology could well have found an alternative venue for publication. But it would be much harder to find another specialist journal featuring the full diversity of this subject area. The intention is to create a unified forum for the full gamut of relevant research, thereby allowing developments and connections across the field to become apparent. We invite you to join us on our journey towards making this a reality.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Affiliations

Queen’s University Belfast, Belfast, UK
Fred Currell
Baylor College of Medicine, Houston, USA
Steven Curley
University of Salford, Manchester, UK
Željka Krpetić
Mark Bellringer, Brighton, UK
Mark Bellringer

Authors

Fred CurrellView author publications
You can also search for this author in PubMed Google Scholar
Steven CurleyView author publications
You can also search for this author in PubMed Google Scholar
Željka KrpetićView author publications
You can also search for this author in PubMed Google Scholar
Mark BellringerView author publications
You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Fred Currell or Mark Bellringer.

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and Permissions

Cite this article

Currell, F., Curley, S., Krpetić, Ž. et al. From basics to clinic: Cancer Nanotechnology . Cancer Nano 8, 8 (2017). https://doi.org/10.1186/s12645-017-0033-1

Download citation

Received: 28 October 2017
Accepted: 31 October 2017
Published: 10 November 2017
DOI: https://doi.org/10.1186/s12645-017-0033-1

中文翻译：

从基础到临床：癌症纳米技术。

癌症是由内在的纳米结构问题（例如DNA问题）驱动的一组疾病。因此，采用纳米级结构和工艺的处理具有明显的好处。此外，随着纳米技术的快速发展，未来几年内该领域可能会出现许多新主题。考虑到这一点，“癌症纳米技术”旨在提供一个论坛，以便最有前途的新兴主题在从事癌症研究或纳米技术的一个或多个学科的研究人员的思想中应占主导地位。

癌症纳米技术由SpringerOpen出版，SpringerOpen是一整套完全开放获取的期刊，隶属于更广泛的Springer Nature集团。随着越来越多的论文获得两位数的引用，它的读者人数不断增加。

当我们接近癌症纳米技术生命的另一年末时，值得反思该杂志的存在理由和未来方向。

标签在锡纸上非常多！癌症纳米技术将自身与癌症研究和纳米技术交汇处的所有新事物联系在一起。与癌症的关系被特意宽泛地解释，包括：预防，治疗，诊断和相关的监管框架。纳米技术被认为是指涉及特征长度尺度通常低于500 nm的物体的任何事物，但也包括诱导纳米尺度过程的过程，例如通过注入能量或各种物质。

这些定义是有意的，期刊继续采用这种方法：接受的投稿范围从基本发现和基本技术的创造（包括开发的所有阶段）到与癌症治疗，诊断和治疗相关的纳米工艺和技术的临床应用。预防。

该期刊的一大特色是举办专题主题文章集。每个集合都用来说明研究领域的现状和/或突出前沿发展。

这样的集合是研究界可以用来使重要的联系明确和广泛传播的工具。此外，主要包括评论文章的收藏集可以显示历史趋势，而专注于原始研究的收藏集可以捕捉颠覆性变化。当然，一个集合可以包含原始研究和评论的组合，从而提供追踪历史趋势和创新不连续性的机会。如果癌症和纳米技术的交汇出现实质性发展，则需要专门的专题文章集-该期刊的编辑团队欢迎您提出这方面的建议。

而且，馆藏的主要特征在于馆藏不断发展。作为仅在线出版物，《癌症纳米技术》不受传统特殊问题（与我们的特殊收藏的印刷类比）规则的束缚。这样就可以使特殊馆藏具有动态性-甚至可以在组成该馆藏的第一批论文发表数年后，根据新的相关研究报告进行更新。

癌症纳米技术中发现的任何论文都有可能找到其他发表场所。但是，要找到另一本涵盖了该学科领域的全部多样性的专业期刊，要困难得多。目的是为整个相关研究领域创建一个统一的论坛，从而使整个领域的发展和联系变得显而易见。我们邀请您加入我们，以实现这一目标。

对于已发布地图和机构隶属关系中的管辖权主张，Springer Nature保持中立。